Hakan Taban

7PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 26, 2026
Clinical Characteristics and Survival Outcomes of a Clinically Defined Treatment-Emergent Neuroendocrine/Aggressive-Variant Prostate Cancer Phenotype: A Retrospective Study.

|Sep 26, 2026
Association of Cabazitaxel Treatment Beyond 10 Cycles with Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Retrospective 8-Month Landmark Analysis.

|May 27, 2026
Prognostic Significance of SULF2 Expression in Surgically Resected Non-Small Cell Lung Cancer.

|Jan 25, 2025
Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach.

Hakan Şat Bozcuk, Leyla Sert, Muhammet Ali Kaplan

|Feb 09, 2023
Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience.

Metin Demir, Denizcan Güven, Burak Yasin Aktaş

|Aug 16, 2021
Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors.

Deniz C Guven, Oktay H Aktepe, Hakan Taban

Pageof 2

Frequent Collaborators

4 joint publications

Denizcan Güven

4 joint publications

Mustafa Erman

4 joint publications

Burak Yasin Aktaş

3 joint publications

Oktay Halit Aktepe